<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="oligo-nucleotide-type"/>
  <meta>
    <lastUpdated value="2026-06-23T16:20:19.822+00:00"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p class="res-header-id">
        <b>Generated Narrative: CodeSystem oligo-nucleotide-type</b>
      </p>
      <a name="oligo-nucleotide-type"> </a>
      <a name="hcoligo-nucleotide-type"> </a>
      <p>This case-sensitive code system 
        <code>http://hl7.org/fhir/oligo-nucleotide-type</code> defines the following codes:
      </p>
      <table class="codes">
        <tr>
          <td style="white-space:nowrap">
            <b>Code</b>
          </td>
          <td>
            <b>Display</b>
          </td>
          <td>
            <b>Definition</b>
          </td>
        </tr>
        <tr>
          <td style="white-space:nowrap">antisense
            <a name="oligo-nucleotide-type-antisense"> </a>
          </td>
          <td>Antisense oligonucleotide</td>
          <td>An antisense oligonucleotide (ASO) that binds to a complementary mRNA sequence to inhibit gene expression.</td>
        </tr>
        <tr>
          <td style="white-space:nowrap">sirna
            <a name="oligo-nucleotide-type-sirna"> </a>
          </td>
          <td>Small interfering RNA (siRNA)</td>
          <td>A short double-stranded RNA that triggers degradation of a target mRNA through the RNA interference pathway.</td>
        </tr>
        <tr>
          <td style="white-space:nowrap">mirna
            <a name="oligo-nucleotide-type-mirna"> </a>
          </td>
          <td>MicroRNA (miRNA)</td>
          <td>A short non-coding RNA that regulates gene expression by base-pairing with target mRNAs.</td>
        </tr>
        <tr>
          <td style="white-space:nowrap">aptamer
            <a name="oligo-nucleotide-type-aptamer"> </a>
          </td>
          <td>Aptamer</td>
          <td>A short single-stranded oligonucleotide that binds a specific target through its three-dimensional structure.</td>
        </tr>
        <tr>
          <td style="white-space:nowrap">decoy
            <a name="oligo-nucleotide-type-decoy"> </a>
          </td>
          <td>Decoy oligonucleotide</td>
          <td>An oligonucleotide that mimics a regulatory binding site to sequester a transcription factor or other binding protein.</td>
        </tr>
        <tr>
          <td style="white-space:nowrap">ribozyme
            <a name="oligo-nucleotide-type-ribozyme"> </a>
          </td>
          <td>Ribozyme / DNAzyme</td>
          <td>A catalytic oligonucleotide capable of cleaving a target nucleic acid.</td>
        </tr>
        <tr>
          <td style="white-space:nowrap">gene-fragment
            <a name="oligo-nucleotide-type-gene-fragment"> </a>
          </td>
          <td>Gene fragment</td>
          <td>A fragment of a gene such as a promoter, enhancer, coding region or silencer.</td>
        </tr>
      </table>
    </div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="brr"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="informative"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="1"/>
  </extension>
  <url value="http://hl7.org/fhir/oligo-nucleotide-type"/>
  <version value="6.0.0-ballot4"/>
  <name value="OligoNucleotideTypeExample"/>
  <title value="Oligonucleotide Type"/>
  <status value="active"/>
  <experimental value="true"/>
  <date value="2026-06-21"/>
  <publisher value="HL7 (FHIR Project)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/fhir"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="fhir@lists.hl7.org"/>
    </telecom>
  </contact>
  <description value="The class of oligonucleotide, where relevant (e.g. antisense, siRNA, aptamer)."/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
      <display value="World"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <valueSet value="http://hl7.org/fhir/ValueSet/oligo-nucleotide-type"/>
  <content value="complete"/>
  <concept>
    <code value="antisense"/>
    <display value="Antisense oligonucleotide"/>
    <definition value="An antisense oligonucleotide (ASO) that binds to a complementary mRNA sequence to inhibit gene expression."/>
  </concept>
  <concept>
    <code value="sirna"/>
    <display value="Small interfering RNA (siRNA)"/>
    <definition value="A short double-stranded RNA that triggers degradation of a target mRNA through the RNA interference pathway."/>
  </concept>
  <concept>
    <code value="mirna"/>
    <display value="MicroRNA (miRNA)"/>
    <definition value="A short non-coding RNA that regulates gene expression by base-pairing with target mRNAs."/>
  </concept>
  <concept>
    <code value="aptamer"/>
    <display value="Aptamer"/>
    <definition value="A short single-stranded oligonucleotide that binds a specific target through its three-dimensional structure."/>
  </concept>
  <concept>
    <code value="decoy"/>
    <display value="Decoy oligonucleotide"/>
    <definition value="An oligonucleotide that mimics a regulatory binding site to sequester a transcription factor or other binding protein."/>
  </concept>
  <concept>
    <code value="ribozyme"/>
    <display value="Ribozyme / DNAzyme"/>
    <definition value="A catalytic oligonucleotide capable of cleaving a target nucleic acid."/>
  </concept>
  <concept>
    <code value="gene-fragment"/>
    <display value="Gene fragment"/>
    <definition value="A fragment of a gene such as a promoter, enhancer, coding region or silencer."/>
  </concept>
</CodeSystem>